Conflicts of Interest


This page will be updated on a monthly basis.

March 2018

Travel and accommodation provided by European Vascular Society to speak at the 22nd European Vascular Course, Maastricht.

January 2018

Travel and accommodation provided by Dr Shashank Joshi to speak at the 17th International Symposium on Diabetes, Mumbai, India.

December 2017

Travel and accommodation provided by Novo Nordisk to attend and present a poster at the International Diabetes Federation meeting in Abu Dhabi

November 2017

Travel and accommodation provided by Sanofi Diabetes to attend an advisory board meeting in London.

Honorarium £1350

Travel, accommodation and honorarium provided by Novo Nordisk to attend a Key Scientific Leaders meeting in Berlin.

September 2017

Travel and accommodation provided by Novo Nordisk to attend and present a poster at the European Association for the Study of Diabetes meeting in Lisbon

Chairing a meeting for Eli Lilly on GLP-1 analogue use

Honorarium £600

So far this year I have also met pharmaceutical reps in my office from:

  • Napp
  • Novo-Nordisk
  • Astra Zeneca
  • Apodi
  • April 2017

    Travel, accommodation and honorarium provided by Novo Nordisk to attend and speak at a Key Scientific Leaders meeting in Vienna.

    Honorarium €4000

    November 2016

    Travel, accommodation and honorarium provided by Novo Nordisk to attend a Key Scientific Leaders meeting in Barcelona.

    August 2016

    Travel and honorarium to attend an internal event for Novo Nordisk for their Medical Affairs Leadership Academy.

    Honorarium €750

    May 2016

    Travel and Accommodation to a Pioneer 6 investigators meeting in Washington DC provided by Novo Nordisk

    April 2016

    Travel for a meeting of the Joint British Diabetes Societies Inpatient Care Group to meet in London was funded by Diabetes UK

    Travel, accommodation and honorarium provided by Novo Nordisk to attend and speak at a Key Scientific Leaders meeting in Paris

    Honorarium £2000

    Travel and accommodation provided by The Association of British Clinical Diabeteologists (ABCD) to attend the 1 day committee meeting and 1 day Annual Spring meeting of ABCD in Edinburgh.

    Honorarium £250

    Travel to speak at International Annual Scientific Meeting of the Association for Clinical Biochemistry and Laboratory Medicine in Warwick

    I am on the clinical end point committee for Lexicon Pharmaceuticals on their trial on Sotagliflozin

    Honorarium £50,000

    October 2015

    Travel and honorarium to speak at the Specsavers Professional Advancement Conference, Oslo, Copenhagen and Stockholm.

    Honorarium £3,750

    Travel, accommodation and honorarium provided by Novo Nordisk to attend and speak at a Key Scientific Leaders meeting in Berlin

    Honorarium £1,500

    September 2015

    Travel to a research meeting provided by Novo Nordisk

    Travel for a meeting of the Joint British Diabetes Societies Inpatient Care Group to meet in London was funded by Diabetes UK

    June 2015

    I spoke at an evening meeting for GP’s and practice nurses sponsored by AstraZeneca in Norwich on why I would not recommend the use of SGLT-2 inhibitors

    Honorarium £500

    Spoke at the 20th annual Norfolk Respiratory Interest Group meeting, Norwich

    Honorarium £250

    April 2015

    Travel and accommodation to attend the 'Wound healing clinical development group' in Amsterdam provided by Genentech.

    Honorarium £4,400

    December 2014

    Travel and accommodation provided by Novo Nordisk to attend a Key Opinion Leaders meeting in Madrid.

    November 2014

    Travel to attend National Audit of Inpatient Diabetes Advisory group and ABCD committee meeting provided by those groups.

    Travel and accommodation to attend a Dulaglutide Speaker training session in Vienna provided by Lilly.

    Honorarium £1250

    October 2014

    Travel and honorarium to speak at the Specsavers Professional Advancement Conference, Birmingham.

    Honorarium £500

    September 2014

    Travel and honorarium to attend a research sub-study meeting for Sanofi-Aventis in Birmingham

    Honorarium £2760

    June 2014

    Travel and accommodation to San Francisco provided by Roche to attend a) the 5th meeting of the Blood Glucose Monitoring Performance Expert Panel and b) a round table meeting to meet with a team developing a new healing product for diabetic foot wounds at Genentech.

    Honorarium $4000

    May 2014

    Travel and accommodation provided by The Association of British Clinical Diabeteologists (ABCD) to attend the 1 day committee meeting and 1 day Annual Spring meeting of ABCD in Edinburgh. I am the meetings secretary and on their executive. I organise their meetings.

    Travel and accommodation provided by Novo Nordisk to attend a Key Opinion Leaders meeting in London.

    March 2014

    I spoke at an evening meeting for GP’s and practice nurses sponsored by Lilly and Boehringer Ingelheim in Great Yarmouth on Driving and Diabetes.

    Honorarium £500

    Travel provided by Diabetes UK to chair a session and speak at their national conference in Liverpool.

    February 2014

    Travel and accommodation provided to attend the 2nd Joint meeting of the Association of British Clinical Diabetologists and the Renal Association provided by ABCD.

    January 2014

    Travel costs to speak in London at the Royal Society of Medicine for the 3rd national diabetes inpatient conference, innovations in diabetes inpatient care provided by the RSM.

    November 2013

    Costs for travel to speak in Dublin at their annual meeting provided by the Irish Orthopaedic Anaesthetists Association.

    I was taken for a meal by the regional sales manager for Novo Nordisk

    Travel and accommodation provided by The Association of British Clinical Diabeteologists (ABCD) to attend the 1 day committee meeting and 1 day Annual Autumn meeting of ABCD in London. I am the meetings secretary and on their executive. I organise their meetings.

    Speaking at the Specialist Registrar meeting of the Association of British Clinical Diabeteologists (ABCD).

    Honorarium £250

    October 2013

    Travel to attend and speak at the Diabetes Inpatient Specialist Nurse UK Group meeting in London provided by the group.

    Honorarium £100

    Travel provided by the Cardio-renal forum for me to speak at their annual conference in London. The topic of my talk is: Do new diabetes drugs hold cardiovascular promise?

    Honorarium £100

    September 2013

    My travel and accommodation to the Heels Trial and the Leukopatch trial meeting in Birmingham were paid for by The HTA and Reapplix.

    Travel and accommodation provided to attend the 3 day Diabetic Foot Study Group meeting in Sitges, Spain. Funding for this is from the research funds generated by the work done in the diabetic foot clinic I lead at the Norfolk and Norwich Hospital.

    Travel to attend Joint British Diabetes Society steering group meeting in London provided by Diabetes UK.

    August 2013

    Travel and accommodation provided to speak at the Jothydev Professional Educational Forum, Trivandrum, India by the Jothydev Diabetes Research Centre.

    Honorarium of Rs 20,000 paid by P Jothydev Trust.

    Also, to speak in Chennai, India on inpatient diabetes, travel and accommodation provided by Novo Nordisk (India).

    No honorarium.

    June 2013

    Travel and accommodation provided by Novo Nordisk to attend the 5 day American Diabetes Association meeting in Chicago.

    Travel for a meeting of the Joint British Diabetes Societies Inpatient Care Group to meet in London was funded by Diabetes UK.

    Travel for a meeting of the editorial board of Practical Diabetes in London was paid for by the journal.

    May 2013

    Travel and accommodation provided by Novo Nordisk to attend a 2 day investigators meeting of the Leader Study in Prague. This is a phase 3b post marketing study comparing cardiovascular outcomes of people with diabetes and high risk of cardiovascular events given liraglutide vs placebo.

    Travel and accommodation provided by Specsavers Finland to speak at their 1 day national Professional Advancement Conference in Helsinki. The topic of my lecture was: Diabetes related eye disease.

    Honorarium €400

    Travel and accommodation provided by Novo Nordisk to attend a 2 day ‘Key Scientific Leaders’ meeting in Madrid.

    No honorarium.

    April 2013

    Travel and accommodation provided by The Association of British Clinical Diabeteologists (ABCD) to attend the 1 day committee meeting and 1 day Annual Spring meeting of ABCD in Solihull. I am the meetings secretary and on their executive. I organise their meetings.

    March 2013

    Travel provided by the Young Diabetologists Forum to speak at their national conference in Manchester. My lecture topic was: Peri-operative diabetes care.

    No honorarium.

    Travel provided by Diabetes UK to speak at their national conference in Manchester. My lecture topic was: JBDS Peri-operative Guidelines’ Impact on Elective Diabetes Care.

    No honorarium.

    I participated in an East Anglian Round Table meeting sponsored by Sanofi – Aventis discussing GLP–1 analogues, and Lixisenatide in particular.

    Honorarium £400

    February 2013

    Travel provided by Sanofi Aventis to teach at the one day Young Diabetologists Forum in Manchester. My lecture topic was: Peri-operative diabetes care.

    No honorarium.

    I spoke at a Practice Nurse seminar at Spire Norwich Hospital. The topic of my talk was: Diabetes, your questions answered.

    My honorarium was a box of chocolates.

    January 2013

    Travel and accommodation provided to attend a 2 day research meeting in Paris – sponsored by Urgo Laboratories, Paris. The foot clinic I lead at the Norfolk and Norwich Hospital is taking part in this multinational study examining the effect of a special wound dressing vs standard wound dressings


    Others

    I am the secretary for the Specialist Clinical Examination in Diabetes and Endocrinology and I have travel and accommodation provided to attend these 1 or 2 day meetings either at the Royal College of Physicians in London or elsewhere in the UK, in February, March, May and October each year.

    Meetings with pharmaceutical representatives

    2015

    During 2015, I have met with representatives from the following companies, either in my office at the Norfolk and Norwich Hospital, or at local (L), national (N) or international (I) conferences.

    • Abbott (L, N)
    • Astra-Zeneca (L)
    • Boehringer Ingelheim (L, N)
    • Ferring (L)
    • Genentec (I)
    • Janssen (L)
    • Lilly (L)
    • Merck, Sharpe, Dohme (L)
    • Novo Nordisk (L, N, I)
    • Prostrakan (L)
    • Roche (L, I)
    • Sanofi Aventis (L, N)

    2014

    During 2014, I have met with representatives from the following companies, either in my office at the Norfolk and Norwich Hospital, or at local (L), national (N) or international (I) conferences.

    • Genentec (N, I)
    • Takeda (L)
    • Lilly (L)
    • Janssen (L)
    • Abbott (L)
    • Sanofi Aventis (L)
    • Boehringer Ingelheim (L)
    • Novo Nordisk (L)
    • Roche (I)
    • Astra-Zeneca (L)
    • Merck, Sharpe, Dohme (L)

    2013

    During 2013, I have met with representatives from the following companies, either in my office at the Norfolk and Norwich Hospital, or at local (L), national (N) or international (I) conferences

    • Astra-Zeneca (L, N)
    • Boehringer Ingelheim (L, N)
    • Bristol Myers Squibb (L, N, I)
    • Ferring (L)
    • Eli Lilly (L, N, I)
    • Janssen-Cilag / Johnson and Johnson (L, N)
    • Merck, Sharpe, Dohme (L, N, I)
    • Novo Nordisk (L, N, I)
    • Pfizer (L, N)
    • Prostrakan (L)
    • Sanofi-Aventis (L, N, I)
    • Takeda (L, N)